<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17038" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Abortion</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ajmal</surname>
            <given-names>Maleeha</given-names>
          </name>
          <aff>Allama Iqbal Med College, Jinnah Hosp</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sunder</surname>
            <given-names>Meera</given-names>
          </name>
          <aff>Cambridge Health Alliance</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akinbinu</surname>
            <given-names>Rotimi</given-names>
          </name>
          <aff>Obafemi Awolowo University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maleeha Ajmal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Meera Sunder declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rotimi Akinbinu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17038.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Abortion is one of the common procedures performed among women. In the U.S., in 2014, one in 5 pregnancies ended in abortion, and one in 4 women is estimated to have an abortion in their lifetime. Globally, one in 4 pregnancies ends in abortion. It is important that all providers understand the prevalence of abortion, the options available, the safety, the restrictions, and the access issues associated with abortion to be able to provide safe and optimal quality of care to the patients. This activity reviews the options available to the woman when she has a positive pregnancy test, describes the various methods of safe abortion care, outlines the indications and contraindications of the various methods of abortion, explains the techniques of performing an abortion, outlines the complications and the steps that help manage these complications.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe options available to a woman with a positive pregnancy test.</p></list-item><list-item><p>Explain the methods of abortion available and describe the pros and cons of each method.</p></list-item><list-item><p>Outline the steps of medical abortion, identify complications and explain how these can be managed.</p></list-item><list-item><p>Review steps of aspiration or surgical abortion, identify complications, and explain how these can be managed.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17038&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17038">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17038.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Abortion is one of the common procedures performed among women. In the US, in 2014, one in 5 pregnancies ended in abortion, and one in 4 women is estimated to have an abortion in their lifetime<xref ref-type="bibr" rid="article-17038.r1">[1]</xref>. Globally, one in 4 pregnancies ends in abortion. It is important that all providers understand the prevalence of abortion, the options available, the safety, the restrictions, and the access issues associated with abortion to be able to provide safe and optimal quality of care to the patients.</p>
        <p>A committee of the National Academies of Sciences, Engineering, and Medicine reviewed the data available and confirmed in their report in 2018 that all forms of abortion, including medication and aspiration abortion, are safe and effective and that the only factors decreasing safety are those decreasing access <xref ref-type="bibr" rid="article-17038.r2">[2]</xref><xref ref-type="bibr" rid="article-17038.r3">[3]</xref>.&#x000a0; First trimester abortions pose no long-term risk of infertility, ectopic pregnancy, spontaneous abortion, or breast cancer.&#x000a0; Abortion does not pose a hazard to a patient&#x02019;s mental health<xref ref-type="bibr" rid="article-17038.r4">[4]</xref>.&#x000a0;</p>
        <p>Abortion can be completed with medication or by a procedure which is often called surgical abortion or aspiration abortion.&#x000a0;The reasons for terminating a pregnancy may be maternal factors or fetal indications. Preabortion workup&#x000a0;often includes obtaining a complete blood count, coagulation profile, type and crossmatch, sexually transmitted infection screen, human chorionic gonadotropin levels, and a pelvic ultrasound to confirm that the pregnancy is intrauterine. Medication abortion can be completed at home. The aspiration abortion is usually performed in a clinic or hospital under local anesthesia, with or without conscious sedation.<xref ref-type="bibr" rid="article-17038.r5">[5]</xref><xref ref-type="bibr" rid="article-17038.r6">[6]</xref><xref ref-type="bibr" rid="article-17038.r7">[7]</xref></p>
      </sec>
      <sec id="article-17038.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>External and internal genitalia typically comprise&#x000a0;the female genital tract. The external genitalia includes:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Mons pubis:</italic>&#x000a0;A rounded mass of fatty tissue lying over the joint of pubic bones.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Labia majora:</italic>&#x000a0;Two cutaneous folds extend from the mons pubis down to the perineum.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Labia minora:</italic>&#x000a0;The region of the female genital tract buried inside the labia majora.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Bartholin gland:</italic>&#x000a0;These are like bulbourethral glands in men and pour lubrication right at the entry of the vagina.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Clitoris: T</italic>he vagina's pea-sized, most heavily innervated organ that detects sensation and stimulation.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Vulva:</italic>&#x000a0;The collective term for women's external genitalia.</p>
          </list-item>
        </list>
        <p>The&#x000a0;female reproductive system's&#x000a0;internal genitalia includes:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Ovaries:</italic>&#x000a0;Female reproductive organs which produce all the ova (eggs) during a&#x000a0;normal menstrual cycle.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Fallopian tubes:</italic>&#x000a0;Also known as uterine tubes, these are responsible for the transportation of ova from the ovaries to the uterus. They are clinically important in abortion because they are&#x000a0;the most common site of ectopic pregnancy (pregnancy outside the uterus).</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Uterus:</italic> The womb is a hormone-sensitive reproductive organ where a fertilized ovum&#x000a0;implants. It is&#x000a0;responsible for nurturing the fertilized ovum and stages of development inside the mother's body that take place in the uterus.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Cervix:</italic>&#x000a0;The lower part of the uterus, or the connection between the uterus and vagina.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Vagina:</italic>&#x000a0;The lowest part of the female genital tract, starting from an external orifice to the cervix.</p>
          </list-item>
        </list>
        <p>Understanding the normal anatomy of the female genital tract helps manage complications of medication abortion and performing the aspiration or surgical abortion.</p>
      </sec>
      <sec id="article-17038.s4" sec-type="Indications">
        <title>Indications</title>
        <p>According to the National Abortion Federation 2020 clinical policy guidelines for abortion care, any patient&#x000a0;choosing to have an abortion must be counseled in a nonjudgmental manner about their options. The patient&#x02019;s desires must be explored, and options including continuing the pregnancy, parenting, adoption, and termination of pregnancy should be discussed during this time. If the patient desires to end the pregnancy, then the benefits, risks, and details of the process need to be discussed.&#x000a0;</p>
        <p>Early medication abortion is non-invasive, avoids the risk of a surgical procedure, and the risk of anesthesia can be done up to 11 weeks. It allows for more privacy and control for the patient. It usually involves the use of medications such as mifepristone and misoprostol and rarely methotrexate<xref ref-type="bibr" rid="article-17038.r8">[8]</xref><xref ref-type="bibr" rid="article-17038.r9">[9]</xref><xref ref-type="bibr" rid="article-17038.r10">[10]</xref>. Medication abortion after the first trimester can also be performed safely and effectively by trained clinicians in settings that are equipped to support the patient. Induced fetal demise may be necessary for later gestational ages.</p>
        <p>Aspiration or surgical abortion involves a procedure and the use of instruments in the vagina, cervix, and uterus to remove the pregnancy. The procedure is usually short. Aspiration&#x000a0;abortion might be needed if medication abortion fails or the woman bleeds heavily during the medication abortion. According to the 2020 National Abortion Federation Clinical Policy Guidelines for Abortion Care, the incidence of aspiration after medication abortion is 2-9% for &#x0003e;63 days LMP and even less to less than 1 to 3% when the second dose of misoprostol is used. The other indication for aspiration or surgical abortion is suspected molar pregnancy <xref ref-type="bibr" rid="article-17038.r11">[11]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17038.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications to medication abortion include</p>
        <list list-type="bullet">
          <list-item>
            <p>IUD in place - may be removed before the medication abortion</p>
          </list-item>
          <list-item>
            <p>Allergy to medication used&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic adrenal failure, especially in patients who are on long-term systemic corticosteroid therapy</p>
          </list-item>
          <list-item>
            <p>Suspected ectopic pregnancy</p>
          </list-item>
          <list-item>
            <p>Hemorrhagic disorders</p>
          </list-item>
          <list-item>
            <p>Anticoagulant therapy, excluding aspirin</p>
          </list-item>
          <list-item>
            <p>Hemodynamic instability&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Inherited porphyria</p>
          </list-item>
        </list>
        <p>Anemia, seizures, asthma on steroid inhalers, obesity, breastfeeding, HIV or AIDs, and sexually transmitted infection are not considered contraindications.&#x000a0;</p>
        <p>Exercise care in case of any coagulopathy or any other bleeding disorder, but these are not contraindications for surgical or aspiration abortion. In case the products of conception are not confirmed on the aspirate after a surgical abortion, trend the HCG levels to ensure ectopic pregnancy or pregnancy of unknown location is ruled out and treated if this is the case.&#x000a0;</p>
      </sec>
      <sec id="article-17038.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>Equipment used for aspiration&#x000a0;abortion includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vacuum single valve&#x000a0;aspirator/Manual vacuum aspirator plus</p>
          </list-item>
          <list-item>
            <p>Locking 60 cc syringe</p>
          </list-item>
          <list-item>
            <p>Cannula</p>
          </list-item>
          <list-item>
            <p>Specimen cup</p>
          </list-item>
          <list-item>
            <p>Standard Graves speculum</p>
          </list-item>
          <list-item>
            <p>Single tooth tenaculum</p>
          </list-item>
          <list-item>
            <p>Ring forceps with cotton</p>
          </list-item>
          <list-item>
            <p>Small polyp forceps</p>
          </list-item>
          <list-item>
            <p>Pratt cervical dilators</p>
          </list-item>
          <list-item>
            <p>Gauze</p>
          </list-item>
          <list-item>
            <p>Curette</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17038.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>
<bold>Medical Abortion</bold>
</p>
        <p>Once the pregnancy test is positive and the patient has opted for abortion, take the following steps to ensure the patient is eligible for medication abortion.</p>
        <p>Confirm the last menstrual period(LMP) and estimate the gestational age(GA). The first day of LMP alone is an accurate means of estimating the gestational age through the mid-first trimester. If the LMP is not known or unreliable, obtain an ultrasound to date the pregnancy. There is no need for an ultrasound prior to medication abortion in all cases<xref ref-type="bibr" rid="article-17038.r12">[12]</xref></p>
        <p>Take a detailed medical history from the patient, including allergies, review of medical conditions, medications, and substance use. Complete a physical exam if indicated by the patient&#x02019;s history and symptoms. Patients choosing medication abortion with a definite LMP do not need a pelvic exam. The pelvic and bimanual exams may be performed prior to the procedure. Patients with no medical conditions do not need routine pre-abortion lab testing. Labs that are recommended include glucose for patients with Insulin Dependent Diabetes Mellitus, INR for those on anticoagulants (warfarin) beyond 12 weeks of GA, rhesus D testing for consenting patients beyond 56 days from LMP and unknown Rh status, hemoglobin and hematocrit only for those with history or symptoms of anemia, gonorrhea and chlamydia testing for those at increased risk or less than 25 years of age. When clinical dating is uncertain, an ultrasound scan is performed to confirm the location and viability of the pregnancy. Combined mifepristone/misoprostol regimens are more effective than misoprostol alone or methotrexate/misoprostol<xref ref-type="bibr" rid="article-17038.r13">[13]</xref>.</p>
        <p>According to the National Abortion Federation (NAF) 2020 guidelines, after counseling the patient about the methods and the pros and cons of the procedure, determine pregnancy dating and eligibility for medication abortion by one of the following.&#x000a0;&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>LMP&#x0003c; or = 77 days from the anticipated date of mifepristone use and</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>First positive pregnancy test was less than 6 weeks ago</p>
              </list-item>
              <list-item>
                <p>No ectopic risk factors, including previous ectopic pregnancy, history of Pelvic Inflammatory Disease, Intra Uterine Device in place at the time of conception, bleeding since LMP, unilateral pelvic pain</p>
              </list-item>
              <list-item>
                <p>Regular menses with no hormonal contraception use 2 months prior to LMP</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>LMP and physical examination, including a bimanual examination if needed</p>
          </list-item>
          <list-item>
            <p>Pelvic ultrasound to date the pregnancy</p>
          </list-item>
        </list>
        <p>Ensure the patient has no contraindications for medication abortion. Obtain signed informed consent, including the manufacturer&#x02019;s patient agreement and medication guide from the patient, after discussing the risks involved in medication abortion and the side effects of the medication.</p>
        <p>Side effects of mifepristone include mainly vaginal bleeding. Side effects of misoprostol include nausea, vomiting, diarrhea, low-grade fever, and muscle aches that resolve within 6 hours of use. If the mifepristone or misoprostol are vomited less than 15 to 30 minutes of use, repeating the dosing can be considered. Antiemetic medications can help manage nausea and vomiting. Vaginal bleeding usually starts 4 to 6 hours after misoprostol use and can be heavy with clots. Patients bleeding heavier than 2 pads per hour or for over 2 hours need to be evaluated by the clinician. Bleeding lasts from 1 to 45 days. Patients need to be informed of the risks, including heavy bleeding that may need additional doses of misoprostol, NSAIDs, the need for aspiration in some cases, the small risk for endometritis, failure of medication abortion needing additional doses of misoprostol or aspiration, teratogenicity of misoprostol. The patient&#x02019;s phone number or email is confirmed. Lastly, transportation for follow-up is ensured.</p>
        <p>
<bold>Surgical Abortion</bold>
</p>
        <p>After taking a detailed medical history, pregnancy must be confirmed, and gestational age must be assessed. Ultrasound is often used to confirm the location of the pregnancy. Baseline vitals, including pulse, and blood pressure, must be performed for all, and a physical exam for those indicated by patient symptoms and history. Confirm and arrange all the instruments required for the procedure ahead of time.&#x000a0;</p>
      </sec>
      <sec id="article-17038.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Medical Abortion</bold>
</p>
        <p>Mifepristone/Misoprostol protocol</p>
        <p>Mifepristone - one 200mg tablet is swallowed on day 1 in the clinic or at home. Misoprostol can be administered in the following routes</p>
        <list list-type="order">
          <list-item>
            <p>Buccally: Four 200mcg tablets are placed between gum and cheek for 30 minutes and swallowed thereafter, 24 to 48 hours after mifepristone administration.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Vaginal: Four 200mcg tablets of misoprostol can also be placed in the vagina 6 to 48 hours after the mifepristone</p>
          </list-item>
          <list-item>
            <p>Sublingual: Two to four 200mcg tablets of misoprostol under the tongue for 30 minutes</p>
          </list-item>
        </list>
        <p>According to the NAF 2020 guidelines, if a patient is &#x0003e; 63 days from LMP, a second dose of 800mcg misoprostol can be administered 4 hours after the first dose. If the patient more than 70 days from LMP, a second dose of 800mcg misoprostol is recommended 4 hours after mifepristone.</p>
        <p>NSAIDs help pain management for the patient while at home<xref ref-type="bibr" rid="article-17038.r14">[14]</xref>,&#x000a0;and the routine prescription of opiates is not necessary. A short prescription for opiates may be prescribed in case NSAIDs are not tolerated or cannot be used due to an allergy. Prophylactic antibiotics are not routinely recommended for medical abortion. Contraception can be discussed if the patient is willing to engage at this time.</p>
        <p>The patient is instructed to contact the provider if&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Bleeding heavily, soaking 2 or more pads in 2 or more consecutive hours</p>
          </list-item>
          <list-item>
            <p>Severe pain that is not responding to the medication prescribed</p>
          </list-item>
          <list-item>
            <p>Fever of more than 100.4 degrees Fahrenheit (38 C) for more than 24 hours after misoprostol</p>
          </list-item>
          <list-item>
            <p>No bleeding within 24 hours of misoprostol</p>
          </list-item>
          <list-item>
            <p>Nausea, vomiting, diarrhea, abdominal pain more than 24 hours after misoprostol</p>
          </list-item>
        </list>
        <p>According to the NAF 2020 guidelines, an ultrasound is not needed to confirm the completion of a successful abortion if using clinical history and home pregnancy tests<xref ref-type="bibr" rid="article-17038.r15">[15]</xref>.&#x000a0;It can be performed by checking baseline serum HCG on the day of mifepristone and one after misoprostol. A decrease of hCG of 50% from baseline by 72 hours, 60% by 4-5 days<xref ref-type="bibr" rid="article-17038.r16">[16]</xref>, and 80% by 7 days from initiating treatment<xref ref-type="bibr" rid="article-17038.r17">[17]</xref>&#x000a0;are confirmative of a successful MAB. It can also be confirmed by ultrasound examination before and after medication administration. An absence of the gestational sac or embryo confirms the success of the abortion.&#x000a0;</p>
        <p>According to the NAF 2020 guidelines, when methotrexate and misoprostol are used, an evidence-based regimen of oral or intramuscular methotrexate followed in three to five days with vaginal misoprostol is recommended for gestations up to 63 days</p>
        <p>
<bold>Surgical/Aspiration Abortion&#x000a0;</bold>
</p>
        <p>Aspiration abortion is performed up to 16 weeks.</p>
        <p>Technique: Don gloves, perform a bimanual examination, and confirm the uterine position and size. Confirm you have all the equipment you need. Adjust table and light, insert the speculum, and evaluate and collect samples for infection screening and testing. Apply the antiseptic solution to the cervix. Administer a paracervical block if the patient is awake. Place the tenaculum on the cervix. Dilate the cervix to the size of the cannula you will be using ( gestational age in weeks + or - 1 to 2 mm). The cervix is dilated using tapered dilators like Pratt or Denniston dilators <xref ref-type="bibr" rid="article-17038.r18">[18]</xref>. Misoprostol can also be used for cervical preparation prior to the procedure <xref ref-type="bibr" rid="article-17038.r19">[19]</xref><xref ref-type="bibr" rid="article-17038.r20">[20]</xref><xref ref-type="bibr" rid="article-17038.r21">[21]</xref>. Osmotic dilators are used when cervical dilation is expected to be difficult. Insert cannula through the cervix with gentle but firm traction on the cervix using the tenaculum. Connect the aspirator to the cannula. The procedure is completed by aspiration of the uterus using a manual or electric vacuum and not by sharp curettage. The procedure is considered complete when the uterus is empty. Ultrasound can be used to confirm the completion of the procedure. Remove the tenaculum and the speculum. Check for the adequacy of the products of conception. If molar pregnancy is suspected, send the tissue to the pathologist for examination. Inform the patient of the complete procedure and the recovery process.&#x000a0;The procedure usually takes&#x000a0;5 to 10 minutes, and antibiotics are given at the end of the procedure to avoid infection.</p>
        <p>Dilatation and evacuation are performed beyond 16 weeks by experienced clinicians in appropriate clinical settings. Intravenous access should be established prior to the procedure. If induced fetal demise is used, appropriate evidence-based protocols must be followed. Osmotic dilators including Dilapan and laminaria, misoprostol, mifepristone, and or other cervical agents are used to achieve adequate dilation. Osmotic dilators may be placed in the cervix prior to the procedure. All instruments entering the uterine cavity must be sterile. Ultrasound should be used during the procedure to locate fetal parts, visualize instruments, and verify the completion of the procedure, thus reducing the risk of uterine perforation and shortening the procedure<xref ref-type="bibr" rid="article-17038.r22">[22]</xref><xref ref-type="bibr" rid="article-17038.r23">[23]</xref>. Uterotonics must be used to help control uterine bleeding during and after the procedure.</p>
      </sec>
      <sec id="article-17038.s9" sec-type="Complications">
        <title>Complications</title>
        <p>&#x000a0;Complications of&#x000a0;<bold>Medication abortion</bold>
<xref ref-type="bibr" rid="article-17038.r10">[10]</xref><xref ref-type="bibr" rid="article-17038.r24">[24]</xref>&#x000a0;and the management options when these arise include the following:</p>
        <list list-type="order">
          <list-item>
            <p>Heavy bleeding and or severe cramping.&#x000a0;</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Repeat misoprostol/NSAIDs</p>
              </list-item>
              <list-item>
                <p>Uterine aspiration&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Blood transfusion<xref ref-type="bibr" rid="article-17038.r25">[25]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Failure of medication abortion</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Uterine aspiration</p>
              </list-item>
              <list-item>
                <p>Repeat misoprostol<xref ref-type="bibr" rid="article-17038.r26">[26]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Infection - endometritis (fever&#x0003e;24 hours after misoprostol, abdominal and pelvic pain, vaginal discharge, uterine/adnexal tenderness)</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Uterine aspiration if retained pregnancy tissue in the uterus and antibiotics per CDC guidelines&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Immediate admission to the hospital will be required if hemodynamically unstable and aggressive treatment with antibiotics.&#x000a0;</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Ectopic pregnancy</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Treat or refer for the next steps&#x000a0;</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p>
<bold>Aspiration Abortion</bold>
<xref ref-type="bibr" rid="article-17038.r27">[27]</xref>
</p>
        <list list-type="order">
          <list-item>
            <p>Vasovagal episode&#x000a0;</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Cool compresses</p>
              </list-item>
              <list-item>
                <p>Elevate legs above the chest</p>
              </list-item>
              <list-item>
                <p>Isometric extremity contractions</p>
              </list-item>
              <list-item>
                <p>Atropine IM 0.4mg or 0.2mg IV, max dose 2mg</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Heavy bleeding - remember 6 Ts<xref ref-type="bibr" rid="article-17038.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Tone - Uterine massage and consider uterotonics like methergine, misoprostol</p>
              </list-item>
              <list-item>
                <p>Tissue - Ensure there is no retained tissue in the uterus&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Trauma - Identify the source of bleeding and address it, especially cervical and vaginal tears</p>
              </list-item>
              <list-item>
                <p>Thrombin - review the history of bleeding and consider additional tests like CBC, coagulation tests, clotting test</p>
              </list-item>
              <list-item>
                <p>Treatment - Consider IV fluid bolus and uterine tamponade with a foley&#x02019;s catheter bulb</p>
              </list-item>
              <list-item>
                <p>Transfer - to the hospital if need be, monitor vitals closely</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Perforation</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Stop the suction, examine the contents of the aspirate for omentum, bowel, products of conception</p>
              </list-item>
              <list-item>
                <p>If stable, continue and complete the procedure under ultrasound guidance. Consider uterotonics and antibiotics. Observe for 1.5 to 2 hours post-procedure.&#x000a0;</p>
              </list-item>
              <list-item>
                <p>If the patient is unstable, transfer&#x000a0;</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Incomplete abortion</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Offer misoprostol or&#x000a0;</p>
              </list-item>
              <list-item>
                <p>Reaspiration if bleeding, in pain or have signs of infection</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Accumulation of blood in the uterus post-procedure - patient usually complains of pain and rectal pressure, and this is usually accompanied by hypotension and or vasovagal&#x000a0; syncope</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Uterine aspiration or uterotonics</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Endometritis (fever, pain, vaginal discharge, leukocytosis)</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Antibiotics per the CDC PID regimen</p>
              </list-item>
              <list-item>
                <p>Ultrasound +/- aspiration procedure</p>
              </list-item>
              <list-item>
                <p>Test for gonorrhea and chlamydia</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Ectopic Pregnancy&#x000a0; - suspect if POC inadequate at the time</p>
          </list-item>
          <list-item>
            <list list-type="order">
              <list-item>
                <p>Transfer to hospital for treatment with methotrexate vs. surgical management</p>
              </list-item>
            </list>
          </list-item>
        </list>
      </sec>
      <sec id="article-17038.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Any woman with a positive pregnancy test should be counseled about her options at the time of the consultation in a nonjudgemental manner. Abortion is an overall safe and effective procedure. Providers should be aware of the prevalence of abortion, the restrictions, and the access issues associated with abortion and strive to provide safe care to patients seeking an abortion.</p>
      </sec>
      <sec id="article-17038.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Abortion is safer when the laws regarding abortion are less restrictive and in countries where the gross national income is higher. The stigma associated with abortion is another recognized barrier to accessing safe abortion and can contribute to the maternal mortality rate worldwide. Overall, ensuring women have better access to reproductive health care, including modern methods of contraception, can ensure the care provided is safe and help reduce maternal and infant mortality rates.</p>
      </sec>
      <sec id="article-17038.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17038&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17038">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17038/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17038">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17038.s13">
        <title>References</title>
        <ref id="article-17038.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Jerman</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Population Group Abortion Rates and Lifetime Incidence of Abortion: United States, 2008-2014.</article-title>
            <source>Am J Public Health</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>107</volume>
            <issue>12</issue>
            <fpage>1904</fpage>
            <page-range>1904-1909</page-range>
            <pub-id pub-id-type="pmid">29048970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Upadhyay</surname>
                <given-names>UD</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zlidar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Weitz</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Incidence of emergency department visits and complications after abortion.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>125</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-183</page-range>
            <pub-id pub-id-type="pmid">25560122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Complications from first-trimester aspiration abortion: a systematic review of the literature.</article-title>
            <source>Contraception</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>92</volume>
            <issue>5</issue>
            <fpage>422</fpage>
            <page-range>422-38</page-range>
            <pub-id pub-id-type="pmid">26238336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biggs</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rowland</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Does abortion increase women's risk for post-traumatic stress? Findings from a prospective longitudinal cohort study.</article-title>
            <source>BMJ Open</source>
            <year>2016</year>
            <month>Feb</month>
            <day>01</day>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>e009698</fpage>
            <pub-id pub-id-type="pmid">26832431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kotta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Molangur</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bipeta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ganesh</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A Cross-Sectional Study of the Psychosocial Problems Following Abortion.</article-title>
            <source>Indian J Psychiatry</source>
            <year>2018</year>
            <season>Apr-Jun</season>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>217</fpage>
            <page-range>217-223</page-range>
            <pub-id pub-id-type="pmid">30166679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>BEY</given-names>
              </name>
              <name>
                <surname>Bartz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Janiak</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>"Without any indication": stigma and a hidden curriculum within medical students' discussion of elective abortion.</article-title>
            <source>Soc Sci Med</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>214</volume>
            <fpage>26</fpage>
            <page-range>26-34</page-range>
            <pub-id pub-id-type="pmid">30138842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vayssi&#x000e8;re</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gaudineau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Attali</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bettahar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eyraud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Faucher</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fournet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hassoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hatchuel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jamin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Letombe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Linet</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Msika Razon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ohanessian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Segain</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vigoureux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Winer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wylomanski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Elective abortion: Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF).</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>222</volume>
            <fpage>95</fpage>
            <page-range>95-101</page-range>
            <pub-id pub-id-type="pmid">29408754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ngoc</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Raghavan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nga</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Dabash</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Diop</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Winikoff</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.</article-title>
            <source>Contraception</source>
            <year>2011</year>
            <month>May</month>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>410</fpage>
            <page-range>410-7</page-range>
            <pub-id pub-id-type="pmid">21477682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blum</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Raghavan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dabash</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ngoc</surname>
                <given-names>Nt</given-names>
              </name>
              <name>
                <surname>Chelli</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hajri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Conkling</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Winikoff</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>166</fpage>
            <page-range>166-71</page-range>
            <pub-id pub-id-type="pmid">22682768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costescu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guilbert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bernardin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fitzsimmons</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Norman</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Pymar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Soon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trouton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>M&#x000c8;</given-names>
              </name>
              <name>
                <surname>Winikoff</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>M</given-names>
              </name>
              <collab>Society of Obstetricians and Gynecologists of Canada</collab>
            </person-group>
            <article-title>Medical Abortion.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>366</fpage>
            <page-range>366-89</page-range>
            <pub-id pub-id-type="pmid">27208607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reeves</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Monmaney</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Creinin</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.</article-title>
            <source>Contraception</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-25</page-range>
            <pub-id pub-id-type="pmid">26285178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bracken</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lichtenberg</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Schweikert</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Tanenhaus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barajas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alpert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Winikoff</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol.</article-title>
            <source>BJOG</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>118</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-23</page-range>
            <pub-id pub-id-type="pmid">21091926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kulier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kapp</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>G&#x000fc;lmezoglu</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hofmeyr</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Campana</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Medical methods for first trimester abortion.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2011</year>
            <month>Nov</month>
            <day>09</day>
            <volume>2011</volume>
            <issue>11</issue>
            <fpage>CD002855</fpage>
            <pub-id pub-id-type="pmid">22071804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colwill</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Bednarek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Edelman</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Opioid Analgesia for Medical Abortion: A Randomized Controlled Trial.</article-title>
            <source>Obstet Gynecol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>134</volume>
            <issue>6</issue>
            <fpage>1163</fpage>
            <page-range>1163-1170</page-range>
            <pub-id pub-id-type="pmid">31764725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt-Hansen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lohr</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Hasler</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Follow-up strategies to confirm the success of&#x000a0;medical abortion of pregnancies up to 10&#x000a0;weeks' gestation: a systematic review with&#x000a0;meta-analyses.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>222</volume>
            <issue>6</issue>
            <fpage>551</fpage>
            <page-range>551-563.e13</page-range>
            <pub-id pub-id-type="pmid">31715147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pocius</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Bartz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stenquist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fortin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.</article-title>
            <source>Contraception</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <page-range>263-268</page-range>
            <pub-id pub-id-type="pmid">27621046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fiala</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Safar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bygdeman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gemzell-Danielsson</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Verifying the effectiveness of medical abortion; ultrasound versus hCG testing.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2003</year>
            <month>Aug</month>
            <day>15</day>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>190</fpage>
            <page-range>190-5</page-range>
            <pub-id pub-id-type="pmid">12860340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hulka</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Lefler</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Anglone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lachenbruch</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>A new electronic force monitor to measure factors influencing cervical dilation for vacuum curettage.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1974</year>
            <month>Sep</month>
            <day>15</day>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>166</fpage>
            <page-range>166-73</page-range>
            <pub-id pub-id-type="pmid">4411687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fong</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Evacuation interval after vaginal misoprostol for preabortion cervical priming: a randomized trial.</article-title>
            <source>Obstet Gynecol</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>431</fpage>
            <page-range>431-4</page-range>
            <pub-id pub-id-type="pmid">10472873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fong</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?</article-title>
            <source>Br J Obstet Gynaecol</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>106</volume>
            <issue>3</issue>
            <fpage>266</fpage>
            <page-range>266-9</page-range>
            <pub-id pub-id-type="pmid">10426647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fong</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming.</article-title>
            <source>Obstet Gynecol</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>92</volume>
            <issue>5</issue>
            <fpage>795</fpage>
            <page-range>795-8</page-range>
            <pub-id pub-id-type="pmid">9794671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darney</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Sweet</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Routine intraoperative ultrasonography for second trimester abortion reduces incidence of uterine perforation.</article-title>
            <source>J Ultrasound Med</source>
            <year>1989</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-5</page-range>
            <pub-id pub-id-type="pmid">2651693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darney</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Atkinson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hirabayashi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Uterine perforation during second-trimester abortion by cervical dilation and instrumental extraction: a review of 15 cases.</article-title>
            <source>Obstet Gynecol</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>75</volume>
            <issue>3 Pt 1</issue>
            <fpage>441</fpage>
            <page-range>441-4</page-range>
            <pub-id pub-id-type="pmid">2304715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <article-title>Practice bulletin no. 143: medical management of first-trimester abortion.</article-title>
            <source>Obstet Gynecol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>676</fpage>
            <page-range>676-692</page-range>
            <pub-id pub-id-type="pmid">24553166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Creinin</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.</article-title>
            <source>Obstet Gynecol</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>126</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-21</page-range>
            <pub-id pub-id-type="pmid">26241251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reeves</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Kudva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Creinin</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac.</article-title>
            <source>Contraception</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>332</fpage>
            <page-range>332-5</page-range>
            <pub-id pub-id-type="pmid">18847584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meirik</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>My Huong</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Piaggio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bergel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>von Hertzen</surname>
                <given-names>H</given-names>
              </name>
              <collab>WHO Research Group on Postovulatory Methods of Fertility Regulation</collab>
            </person-group>
            <article-title>Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicentre randomised trial.</article-title>
            <source>Lancet</source>
            <year>2012</year>
            <month>May</month>
            <day>12</day>
            <volume>379</volume>
            <issue>9828</issue>
            <fpage>1817</fpage>
            <page-range>1817-24</page-range>
            <pub-id pub-id-type="pmid">22405255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17038.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerns</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Steinauer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Management of postabortion hemorrhage: release date November 2012 SFP Guideline #20131.</article-title>
            <source>Contraception</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>331</fpage>
            <page-range>331-42</page-range>
            <pub-id pub-id-type="pmid">23218863</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
